Equities analysts expect that Colgate-Palmolive (NYSE:CL) will report $4.01 billion in sales for the current quarter, according to Zacks. Eight analysts have issued estimates for Colgate-Palmolive’s earnings, with estimates ranging from $3.95 billion to $4.09 billion. Colgate-Palmolive reported sales of $3.76 billion in the same quarter last year, which would suggest a positive year over year growth rate of 6.6%. The business is scheduled to announce its next quarterly earnings results on Friday, April 27th.
According to Zacks, analysts expect that Colgate-Palmolive will report full-year sales of $4.01 billion for the current fiscal year, with estimates ranging from $16.09 billion to $16.57 billion. For the next financial year, analysts anticipate that the firm will report sales of $16.82 billion per share, with estimates ranging from $16.62 billion to $17.14 billion. Zacks’ sales calculations are a mean average based on a survey of research analysts that cover Colgate-Palmolive.
Colgate-Palmolive (NYSE:CL) last announced its earnings results on Friday, January 26th. The company reported $0.75 earnings per share (EPS) for the quarter, meeting analysts’ consensus estimates of $0.75. Colgate-Palmolive had a return on equity of 1,716.69% and a net margin of 13.10%. The firm had revenue of $3.89 billion for the quarter, compared to analyst estimates of $3.92 billion. During the same quarter last year, the firm posted $0.75 EPS. The business’s revenue was up 4.6% on a year-over-year basis.
Colgate-Palmolive (NYSE:CL) opened at $70.87 on Wednesday. Colgate-Palmolive has a 52-week low of $68.19 and a 52-week high of $77.91. The stock has a market capitalization of $62,218.23, a P/E ratio of 31.08, a PEG ratio of 2.63 and a beta of 0.79. The company has a debt-to-equity ratio of 27.02, a quick ratio of 1.00 and a current ratio of 1.36.
The company also recently disclosed a quarterly dividend, which will be paid on Tuesday, May 15th. Investors of record on Friday, April 20th will be paid a $0.42 dividend. This is an increase from Colgate-Palmolive’s previous quarterly dividend of $0.40. This represents a $1.68 annualized dividend and a yield of 2.37%. The ex-dividend date is Thursday, April 19th. Colgate-Palmolive’s dividend payout ratio is currently 70.18%.
In other Colgate-Palmolive news, VP Henning I. Jakobsen sold 36,215 shares of the firm’s stock in a transaction on Monday, February 5th. The stock was sold at an average price of $71.22, for a total value of $2,579,232.30. Following the completion of the sale, the vice president now directly owns 70,783 shares of the company’s stock, valued at approximately $5,041,165.26. The sale was disclosed in a filing with the Securities & Exchange Commission, which can be accessed through this hyperlink. Also, SVP John J. Huston sold 14,000 shares of the firm’s stock in a transaction on Friday, February 9th. The stock was sold at an average price of $69.44, for a total value of $972,160.00. Following the completion of the sale, the senior vice president now directly owns 100,508 shares of the company’s stock, valued at $6,979,275.52. The disclosure for this sale can be found here. Over the last three months, insiders sold 455,707 shares of company stock valued at $32,443,427. 1.02% of the stock is owned by corporate insiders.
Several institutional investors and hedge funds have recently modified their holdings of CL. Jacobi Capital Management LLC increased its position in shares of Colgate-Palmolive by 125.5% during the 3rd quarter. Jacobi Capital Management LLC now owns 1,443 shares of the company’s stock worth $104,000 after purchasing an additional 803 shares during the last quarter. Virtue Capital Management LLC acquired a new stake in shares of Colgate-Palmolive during the 4th quarter worth about $104,000. Krilogy Financial LLC increased its position in shares of Colgate-Palmolive by 23.0% during the 2nd quarter. Krilogy Financial LLC now owns 1,547 shares of the company’s stock worth $115,000 after purchasing an additional 289 shares during the last quarter. Captrust Financial Advisors acquired a new stake in shares of Colgate-Palmolive during the 2nd quarter worth about $122,000. Finally, Bruderman Asset Management LLC acquired a new stake in shares of Colgate-Palmolive during the 2nd quarter worth about $126,000. 73.87% of the stock is owned by institutional investors and hedge funds.
Colgate-Palmolive Company Profile
Colgate-Palmolive Company (Colgate) is a consumer products company. The Company operates in two product segments: Oral, Personal and Home Care, and Pet Nutrition. The Oral, Personal and Home Care product segment is operated through five geographic segments, which include North America, Latin America, Europe, Asia Pacific and Africa/Eurasia.
For more information about research offerings from Zacks Investment Research, visit Zacks.com
Receive News & Ratings for Colgate-Palmolive Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Colgate-Palmolive and related companies with MarketBeat.com's FREE daily email newsletter.